We confirmed this finding by performing meta-analysis of multiple independent FSHD published transcriptomic datasets, demonstrating that elevated FAP gene expression is a clear feature of FSHD muscle across 130 FSHD samples. The gene discussed is FAP; the disease is facioscapulohumeral muscular dystrophy.